FdaApplication
ANDA 203166
Identifiers
- fda_app_no: ANDA203166
Properties
| Property | Value |
|---|---|
| applicant_name | LGM PHARMA SOLUTIONS LLC |
| application_type | ANDA |
| approval_date | 2019-08-30 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NABUMETONE | NABUMETONE | 500MG | TABLET;ORAL |
| NABUMETONE | NABUMETONE | 750MG | TABLET;ORAL |
| NABUMETONE | NABUMETONE | 1GM | TABLET;ORAL |
3 products